Objective -To audit the use of bronchial arteriography and embolisation for controlling haemoptysis.
Introduction
In patients with troublesome haemoptysis bronchial artery embolisation is sometimes undertaken with the objective of stopping the haemorrhage. There is no defined list of the indications for embolisation, although most patients treated in published series have experienced recurrent haemoptyses in excess of 100 ml per episode. Recent editorials' 2 and a topical review3 highlighted success rates of 75-90% for bronchial artery embolisation in controlling haemoptysis, based on three large studies in the world literature. 6 The populations studied are very different, in 16 of 49 patients from France4 and 70 of 75 patients from Brazil5 the underlying diagnosis was tuberculosis. Abscess or pneumonia was the underlying disease in 1 18 of 306 patients from the former Soviet Union.6 Our two hospitals receive many tertiary referrals, and the patients have a different range of disease. In particular, Brompton Hospital has a large population of between 400 and 500 adult patients with cystic fibrosis. The aims of our study were to ascertain the characteristics of our population and the success rate of bronchial artery embolisation in this population and to assess the appropriateness of each procedure.
Patients and methods

PATIENTS
We undertook a retrospective search of the radiological records of patients at the Royal Brompton and Heart Hospitals between 1 January 1984 and 31 December 1989 to identify bronchial arteriography performed with the intention of embolisation to stop haemoptysis. The arteriograms were reviewed with reference to the clinical data obtained from the patients' medical records.
Major haemoptysis was defined in this study as an episode during which at least 100 ml of blood was expectorated during a single bout of coughing. Otherwise the episode was defined as a minor haemoptysis. Assessment of the size of each haemoptysis was based primarily on the volumes of expectorated blood recorded by the nursing staff.
BRONCHIAL ARTERY EMBOLISATION
All patients were catheterised through a transfemoral approach using an end hole preformed catheter. As the bronchial arteries normally arise from the descending aorta a search was made between the fourth and sixth thoracic vertebrae, using the air in the left main bronchus as an anatomical landmark. There is a wide variation in the pattern of bronchial artery distribution, at least 10 different types being described in published 
PROCEDURES NO I INCLUDED IN MAIN ANALYSIS
Of the original 58 procedures, 18 were not considered in the main analysis. Nine procedures in eight patients followed episodes of minor haemoptysis, and all of these patients subsequently rebled. Seven procedures for major haemoptysis in four patients were undertaken more than one week after the episode of major haemoptysis. No further major haemoptysis occurred in the 10 days after these procedures. However, it is impossible to determine whether cessation of the haemoptysis was the result of the embolisation or not.
In one patient embolisation was successful for a major haemoptysis which followed laser treatment for carcinoma of the bronchus. Inadequate clinical data were available to allow evaluation of one procedure.
Discussion
There are no agreed rules for deciding whether bronchial artery embolisation is an appropriate treatment intervention in individual cases. As a result we decided in our audit to use the results of our retrospective analysis, itself, and the published series to evaluate the appropriateness of the procedure on each occasion and to develop guidelines for the future.
The success rate of the procedure for the control of major recent haemoptysis was 40% (16/40) . This result is similar to that of 53%(8/15) in a study of patients with cystic fibrosis.8 However, it seems to compare unfavourably with the large series previously reported 6 and two recent studies in the United States (of 20 and 25 patients respectively with cystic fibrosis) which reported 950'Vo and 84% success rates respectively for control of haemoptysis.9 '°T here are several important reasons for the apparent differences in success rate. Firstly, our success rate (16/40) is based on the evaluation of a rigorously defined subgroup of patients in whom recent major haemoptysis was clearly recorded. In the recent study by Cohen et al patients with cystic fibrosis with smaller amounts of haemoptysis were included in the calculation of success rate.9 In that study patients with chronic or slowly increasing haemoptysis interfering with lifestyle and with haemoptysis preventing postural drainage or home management were selected for angiography9; these patients may have stopped bleeding spontaneously and are, therefore, more difficult to evaluate objectively. Secondly, the range and severity of underlying disease in our patients are different from those in other series.4 6 Bronchial artery embolisation will reduce blood pressure and blood flow at the site of haemorrhage, but alone it will not abolish haemorrhage. Cessation of haemorrhage also requires blood clotting and repair of blood vessels. Inflammation, for example in chronic bronchial sepsis, is difficult to abolish in patients with severe disease and probably impairs repair of vessels. The low efficacy of bronchial artery embolisation in our patients highlights the need to try to stop haemorrhage by intensive antibiotic treatment and judicious use of physiotherapy. Botenga proposed that successful treatment of the inflammatory process may lead to the disappearance of bronchopulmonary anastomoses." The prolongation of prothrombin time recorded in five patients was minor, and vitamin K was administered.
As a consequence of this audit our radiologists limit the use of bronchial arteriography and embolisation to patients with recent major haemoptysis. The procedure is no longer undertaken for minor haemoptysis or past (> 1 week) major haemoptysis. Repeat procedures after technically successful embolisation are now only reluctantly undertaken. If these restrictions had been applied to the patient population studied in this audit up to 43% fewer procedures would have been performed with no loss of clinical benefit. Bronchial embolisation is safe whereas the alternatives, such as surgery and more extensive arteriography, may be more hazardous in this population of patients. Pleural changes after thoracotomy are a relative contraindication to future lung transplantation. The criteria identified above are now applied when discussing potential embolisations with referring clinicians. In this manner, we aim to avoid inappropriate procedures.
We thank the physicians and radiologists whose patients are included in this audit.
